OSE Immunotherapeutics (OSE) - Financial and Strategic SWOT Analysis Review

  • ID: 4278791
  • SWOT Analysis
  • 25 pages
  • GlobalData
1 of 4

OSE Immunotherapeutics (OSE), formerly OSE Pharma SA is a biotechnology company that discovers and develops immunotherapy products against invasive and metastatic late-stage cancers. The company’s memopi technology is employed in studying the development of treatments for ovarian, colon and breast cancer. Its products include tedopi and effi-7. OSE’s Effi-7 is in preclinical development and targets autoimmune diseases and transplantation. The company’s tedopi stimulates cytotoxic killer T cells and relearns them to detect cancer cells to eliminate them. It markets its products through its distribution network. OSE is headquartered in Nantes, France.

OSE Immunotherapeutics Key Recent Developments

Jan 03, 2018: OSE Immunotherapeutics Announces Appointment of Gerard Tardy as Chairman of Company’s Board of Directors
Sep 07, 2017: OSE Immunotherapeutics Reports on First-Half 2017 Financial Results and Provides Update on Clinical Advances of Its Product Portfolio
May 18, 2017: OSE Immunotherapeutics to Present at Annual Sachs Immuno-Oncology: BD&L and Investment Forum

This comprehensive SWOT profile of OSE Immunotherapeutics provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of OSE Immunotherapeutics including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • OSE Immunotherapeutics - Key Information
  • OSE Immunotherapeutics - Overview
  • OSE Immunotherapeutics - Key Employees
  • OSE Immunotherapeutics - Key Employee Biographies
  • OSE Immunotherapeutics - Key Operational Heads
  • OSE Immunotherapeutics - Major Products and Services
  • OSE Immunotherapeutics - History
  • OSE Immunotherapeutics - Company Statement
  • OSE Immunotherapeutics - Locations And Subsidiaries
  • OSE Immunotherapeutics - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • OSE Immunotherapeutics - Business Description
  • OSE Immunotherapeutics - Corporate Strategy
  • OSE Immunotherapeutics - SWOT Analysis
  • SWOT Analysis - Overview
  • OSE Immunotherapeutics - Strengths
  • OSE Immunotherapeutics - Weaknesses
  • OSE Immunotherapeutics - Opportunities
  • OSE Immunotherapeutics - Threats
  • OSE Immunotherapeutics - Key Competitors
Section 3 - Company Financial Performance Charts
  • OSE Immunotherapeutics - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • OSE Immunotherapeutics, Key Information
  • OSE Immunotherapeutics, Key Ratios
  • OSE Immunotherapeutics, Share Data
  • OSE Immunotherapeutics, Major Products and Services
  • OSE Immunotherapeutics, History
  • OSE Immunotherapeutics, Key Employees
  • OSE Immunotherapeutics, Key Employee Biographies
  • OSE Immunotherapeutics, Key Operational Heads
  • OSE Immunotherapeutics, Other Locations
  • OSE Immunotherapeutics, Subsidiaries
  • OSE Immunotherapeutics, Key Manufacturing facilities
  • OSE Immunotherapeutics, Key Competitors
  • OSE Immunotherapeutics, SWOT Analysis
  • OSE Immunotherapeutics, Ratios based on current share price
  • OSE Immunotherapeutics, Annual Ratios
  • OSE Immunotherapeutics, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • OSE Immunotherapeutics, Performance Chart
  • OSE Immunotherapeutics, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4


4 of 4
Note: Product cover images may vary from those shown